Giuseppina Improta
Rionero In Vulture, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
CTNNB1 Mutations in Non-small Cell Lung Cancer: Clinicopathological Characteristics of a Small Cohort.
Journal: Anticancer research
Published: May 04, 2026
Molecular Features of Gastrointestinal Stromal Tumors: A Single Referral Cancer Center Experience.
Journal: Anticancer research
Published: February 13, 2026
NRASQ61K/R/L Mutant Allele Frequency in Melanoma and its Correlation With Clinicopathological Characteristics.
Journal: Anticancer research
Published: January 28, 2025
EGFR Exon 19 Insertions: Do Patients Respond to Tyrosine Kinase Inhibitor Treatment?
Journal: Anticancer research
Published: November 26, 2024
PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine.
Journal: Journal for immunotherapy of cancer
Published: September 20, 2021
Ovarian Clear Cell Carcinoma: From Morphology to Molecular Biology.
Journal: Applied immunohistochemistry & molecular morphology : AIMM
Published: April 10, 2018
Uncommon frame-shift exon 19 EGFR mutations are sensitive to EGFR tyrosine kinase inhibitors in non-small cell lung carcinoma.
Journal: Medical oncology (Northwood, London, England)
Published: November 22, 2017
Sentinel Node Biopsy in Melanoma: Lessons Learned From Different Positivity Rates From Different Hospitals.
Journal: Annals of surgery
Published: November 16, 2017
MGMT promoter methylation status in Merkel cell carcinoma: in vitro versus invivo.
Journal: Journal of cancer research and clinical oncology
Published: January 25, 2017
Molecular status of PI3KCA, KRAS and BRAF in ovarian clear cell carcinoma: an analysis of 63 patients.
Journal: Journal of clinical pathology
Published: March 29, 2016
Epidermotropic progression of melanoma during therapy with vemurafenib and trametinib.
Journal: Journal of the American Academy of Dermatology
Published: January 13, 2016
New developments in the management of advanced melanoma - role of pembrolizumab.
Journal: OncoTargets and therapy
Published: September 24, 2015
Last Updated: 09/26/2026